Medartis Holding AGXSWX:MED +4.28%76 Days Payable is 57.40 as of Dec. 2025, which is 47% below its 10-year median of 107.84. GuruFocus rates XSWX:MED with a GF Score™ of 76/100 and a GF Value™ of CHF105.66 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 795 Medical Devices & Instruments companies, Medartis Holding AG ranks worse than 54.72% on this metric.
The historical rank and industry rank for Medartis Holding AG's Days Payable or its related term are showing as below:
XSWX:MED'
s Days Payable Range Over the Past 10 Years
Min: 63.42 Med: 107.84 Max: 167.89
Current: 63.42
During the past 12 years, Medartis Holding AG's highest Days Payable was 167.89. The lowest was 63.42. And the median was 107.84.
XSWX:MED's Days Payable is ranked worse than 54.72% of 795
companies
in the Medical Devices & Instruments industry
Industry Median: 67.87
vs XSWX:MED: 63.42
Medartis Holding AG's Days Payable
declined
from Dec. 2024 (61.82) to Dec. 2025 (57.40).
It may suggest that Medartis Holding AGaccelerated paying its suppliers.
Medartis Holding AG Days Payable Related Terms
Medartis Holding AG Days Payable Historical Data
* Premium members only.
The historical data trend for Medartis Holding AG's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XSWX:MED vs ABT, SYK, MDT: Days Payable Comparison
For the Medical Devices subindustry, Medartis Holding AG's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medartis Holding AG Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Medartis Holding AG's Days Payable distribution charts can be found below:
* The bar in red indicates where Medartis Holding AG's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Medartis Holding AG's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medartis Holding AG (XSWX:MED) has a Days Payable of 57.40 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Medartis Holding AG and its competitors. This is 47% below median its historical median of 107.84. Over the past decade, Medartis Holding AG's Days Payable has ranged from 63.42 to 167.89. According to the industry distribution chart, Medartis Holding AG ranks #435 out of 795 companies in the Medical Devices & Instruments industry, placing it in the top 54.7%.
Is Medartis Holding AG's Days Payable too high?
Medartis Holding AG's current Days Payable of 57.40 is 47% below median its 10-year median of 107.84. Over the past 10 years, this metric has ranged from a low of 63.42 to a high of 167.89. The Medical Devices & Instruments industry median Days Payable is 67.87. Medartis Holding AG's value of 57.40 is 15.4% below this industry median. Based on the distribution chart, Medartis Holding AG ranks #435 out of 795 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Medartis Holding AG has a GF Score™ of 76/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Medartis Holding AG's Days Payable compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Medartis Holding AG ranks #435 out of 795 companies for Days Payable. This places Medartis Holding AG in the lower half of its industry. The industry median Days Payable is 67.87. Medartis Holding AG's value of 57.40 is 15.4% below this benchmark. Historically, Medartis Holding AG's own Days Payable has ranged from 63.42 to 167.89 over the past decade. While the company's 10-year median is 107.84 vs. the industry median of 67.87, Medartis Holding AG has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 67.87, based on 795 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medartis Holding AG's current Days Payable of 57.40 is 15.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Medartis Holding AG and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 67.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medartis Holding AG's current Days Payable is 57.40, which is 47% below median its own 10-year median of 107.84. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medartis Holding AG stock overvalued right now?
Based on GuruFocus' analysis, Medartis Holding AG (XSWX:MED) is currently considered Modestly Undervalued. The stock's GF Value™ is CHF105.66, compared to a current price of CHF80.40 — trading 23.9% below its estimated fair value. The current Days Payable is 57.40, which is 47% below median its 10-year median of 107.84 and 15.4% below the Medical Devices & Instruments industry median of 67.87. Medartis Holding AG's overall GF Score™ is 76/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Medartis Holding AG (XSWX:MED), the current Days Payable is 57.40 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medartis Holding AG (XSWX:MED) Overvalued in 2026?
Based on GuruFocus' analysis, Medartis Holding AG stock appears to be undervalued.
The current stock price of CHF80.40 is trading 23.9% below its estimated GF Value™ of CHF105.66.
GuruFocus considers Medartis Holding AG to be Modestly Undervalued.
Key valuation signals for XSWX:MED:
Days Payable: 57.40 (47% below median its 10-year median of 107.84)
GF Value™: CHF105.66 vs. price of CHF80.40 (23.9% below fair value)
Industry Position: 15.4% below the Medical Devices & Instruments median (#435 of 795)
No single metric tells the full story. See the XSWX:MED stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medartis Holding AG is a medical device company. The company's product profile is divided into APTUS products, StealthFix Products, and MODUS products. APTUS includes products for the Hand, Wrist, Elbow, Shoulder, and Foot. MODUS comprises products for the mandible. Geographically, it derives the majority of its revenue from Europe, Middle East and Africa (EMEA) and also has a presence in North America, Asia Pacific, and Latin America.
76GF Score
Get the complete analysis for XSWX:MED
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:MED has been successfully added to your 
